Oral Dosage Form New Animal Drugs; Ivermectin With Pyrantel Pamoate

Resumen

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Merck Research Laboratories, Division of Merck & Co., Inc., for chewable tablets containing ivermectin with pyrantel pamoate. The product is used to prevent canine heartworm disease and to treat and control ascarid and hookworm infections. The supplemental NADA provides for expanding the use for the treatment and control of an additional adult hookworm infection.